Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones. — ME/CFS Atlas
Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones.
Cevik, Remzi, Gur, Ali, Acar, Suat et al. · BMC musculoskeletal disorders · 2004 · DOI
Quick Summary
This study examined hormone levels in women with ME/CFS, focusing on hormones that control the menstrual cycle and stress response. Researchers found that women with ME/CFS had lower stress hormone (cortisol) levels than healthy women, while menstrual cycle hormones were normal. Depression symptoms did not change these hormone patterns.
Why It Matters
This study provides evidence that the hormonal abnormalities in ME/CFS may involve the stress response system (HPA axis) rather than reproductive hormones, suggesting the condition involves distinct biological mechanisms. Understanding these hormonal patterns could help differentiate ME/CFS from primary psychiatric conditions and guide future treatment approaches.
Observed Findings
Cortisol levels were significantly lower in CFS patients compared to matched healthy controls
FSH, LH, estradiol, and progesterone levels showed no significant differences between CFS patients and controls in both menstrual phases
No significant differences in hormone levels were found between CFS patients with high depression scores versus low depression scores
Hormonal patterns remained consistent across follicular and luteal menstrual phases in CFS patients
Inferred Conclusions
Low cortisol concentration represents a characteristic hormonal abnormality in premenopausal women with CFS
Depression associated with CFS may have different biological mechanisms than classical depression, since hormone levels did not vary with depression severity
Pathophysiology of CFS may involve HPA axis dysfunction independent of HPG axis function
Depression and hormonal abnormalities in CFS warrant evaluation of both HPG and HPA axes for accurate diagnosis and treatment planning
Remaining Questions
Does cortisol dysfunction improve or worsen over time, and does it correlate with symptom severity or disease progression?
What mechanisms explain the low cortisol in CFS, and is this a primary defect or secondary to chronic illness?
What This Study Does Not Prove
This cross-sectional study cannot establish causation—low cortisol may be a consequence of CFS rather than a cause. The findings apply only to premenopausal women and cannot be generalized to men, postmenopausal women, or all CFS presentations. A single cortisol measurement may not capture full HPA axis dysfunction, which often requires dynamic testing.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
How do hormonal patterns differ in postmenopausal women, men, or adolescents with CFS compared to this premenopausal female cohort?
Could dynamic HPA axis testing (such as dexamethasone suppression tests or ACTH stimulation) reveal more subtle endocrine abnormalities than static cortisol measurements?